Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
  Pharmaceutical Technology Europe E-Alert
 
21 January 2011

IN THIS ISSUE
Avandia legal costs
J&J recall
EU patent agreements
FDA guidance

 
Avandia costs GSK $3.4 billion
GlaxoSmithKline is expecting to pay $3.4 billion to settle legal charges relating to its diabetes drug Avandia, as well as sales and promotional practices in the US for other products. More...
 
J&J recalls yet more medicines
Johnson & Johnson’s run of quality issues, recalls and other bad news continues with yet another product recall. More...
 
EU examines patent settlements
The EU Commission is on the lookout for “potentially problematic patent settlements” and has asked several pharma companies to submit copies of their patent settlement agreements made between originator and generic companies. More...
 
FDA issues draft guidance on capsule bead size
The FDA has issued draft guidance for industry about the size of beads within drug products labelled for sprinkle. More...
 
Join our community on LinkedIn
Want to discuss any of this week’s news stories or any other hot topics in the industry? Then why not join our group on LinkedIn? More...

Latest blog posts
Will the vise tighten on pay-for-delay agreements?
India rising
The latest Sanofi/Genzyme rumors
More blog posts

Peer-reviewed research
Printable medicines: a microdosing device for producing personalised medicines
An initial report of CDER's recall root cause research project (Part II)
A comparison of three extrusion systems
More articles

Upcoming events
Informex USA 2011 (7–10 February | USA)
Cleanrooms — Standards & Technology (8 February | UK)
Pharma World Expo 2011 (23–26 February | UK)
More events

Product Profiles
Oxoid

QC Organisms for performance qualification of culture media
Quanti-Cult Plus™ quality control micro-organisms are ideal for use in pharmaceutical applications such as growth promotion testing and method validation. They are convenient to use with each aliquot guaranteed to deliver <100 CFU and only 3 passages from the ATTC® strain. Once reconstituted they are stable for up to 8 hours at 2-8C. Read more...

 
Vetter

A comprehensive portfolio of drug-delivery systems
Vetter, a leading independent international specialist in aseptic filling, offers a broad portfolio of drug-delivery systems.
Read more


Event Profile
 
placeholder

Pharma Test Expo
8-10 February 2011

Cologne, Germany

Test professionals can hear the latest on the subject at Pharma Test Expo 2011, to be held next February 8-10, in Cologne, Germany. Read more

 

 



Survey
Which granulation technique is most commonly used in your company?
Wet granulation 76%
 
Dry granulation 24%

This week we would like to know...

FDA recently was granted the authority to issue recalls for food products. Should the agency have this power for pharmaceuticals as well?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail
at Advanstar Communications Inc., Advanstar House, Park West, Sealand Road, Chester, CH1 4RN United Kingdom